Laboratory Medicine
Test catalogue
Anti-IIa Inhibitor (Dabigatran, Pradaxa) | |
---|---|
Test NameAnti-IIa Inhibitor (Dabigatran, Pradaxa) |
|
Specimen Type / RequirementsContainer Type = Blue (Sodium Citrate) Minimum Testing Volume = Full draw 9:1 Ratio (9 parts blood to 1 part anticoagulant) |
|
Specimen HandlingCollection Instructions: Must indicate anticoagulant status to avoid delay. Write your initials, date and time of collection on the collection label. Transportation: In/Outpatients: Send whole citrated blood at room temperature as soon as possible. Referred-in: Send frozen citrated plasma on dry ice. All samples must be sent to the Core Laboratory. Stability: Specimens are stable for 4 hours post collection at room temperature. Specimens which are not tested within 4 hours can be double-spun to remove the citrated plasma. The citrated plasma is stable at -20°C for up to two weeks or -70°C for up to six months. Sample Rejection Criteria: Clotted sample, grossly hemolyzed samples, Unlabeled or samples with insufficient quantity will be rejected. |
|
Required Documentation |
|
Turnaround Time (TAT)STAT: 4 hrs Routine: 1 day |
Test Utilization |
Reference ValuePeak Level (measured at 2-3 hours after dose) in patients on Dabigatran 150 mg bid = 60.00 – 440.00 ng/mL Trough Level (measured at 12 hours after dose) in patients on Dabigatran 150 mg bid = 30.00 – 230.00 ng/mL |
|
Test CodeDABI |
MethodologyClotting Assay |
Testing LocationSMH-Routine Coagulation |
Other informationLast Updated: June 06, 2019 |